News from Esperion Therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jan 07, 2013, 06:00 ET Esperion Announces Positive Topline Results from a Phase 2 Clinical Trial of ETC-1002 in Patients with Type 2 Diabetes

 Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, today announced...


Jan 04, 2013, 09:00 ET Tim Mayleben Named President And CEO Of Esperion Therapeutics

 Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, today...


Mar 26, 2012, 09:00 ET Esperion Announces Positive Phase 2 Clinical Trial Results for ETC-1002

 Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for...


May 02, 2011, 09:00 ET Esperion Announces Results From Phase 1 Study and Four Preclinical Studies for ETC-1002

Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and...


Jun 14, 2010, 09:00 ET Esperion Therapeutics and Cleveland Clinic Establish Collaboration for Research Related to HDL Therapies

Esperion Therapeutics, a privately held biopharmaceutical company working to discover, develop and commercialize treatments for cardiovascular and...